|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.42 USD | +0.92% |
|
-0.44% | -40.82% |
| Apr. 02 | Inari Medical, Inc. Appoints Tim Benner as Senior Vice President of U.S. Sales | CI |
| Apr. 01 | Inari Medical, Inc.(NasdaqGS:NARI) added to S&P 600 Health Care | CI |
Inari Medical, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 493.63 million compared to USD 383.47 million a year ago. Net loss was USD 1.64 million compared to USD 29.27 million a year ago.
Basic loss per share from continuing operations was USD 0.03 compared to USD 0.55 a year ago. Diluted loss per share from continuing operations was USD 0.03 compared to USD 0.55 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -40.82% | 2.23B | |
| +73.17% | 12.38B | |
| -18.74% | 7.92B | |
| +16.15% | 7.2B | |
| +4.81% | 5.84B | |
| +5.99% | 5.01B | |
| +27.07% | 4.53B | |
| -21.67% | 3.88B | |
| +1.49% | 2.02B | |
| +5.07% | 1.88B |
INARI MEDICAL, INC. 
